Soma 350mg contains carisoprodol, a prescription skeletal muscle relaxant used to relieve discomfort associated with acute, painful musculoskeletal conditions in adults. It is generally used alongside rest, physical therapy, and other supportive measures rather than as a stand-alone treatment.
For official prescribing information, precautions, contraindications, and approved uses, refer to the FDA-approved DailyMed labeling for SOMA.
Soma 350mg is prescribed for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults. It may be incorporated into a broader treatment plan that includes rest and physical therapy.
Carisoprodol affects the central nervous system and can help reduce muscle discomfort and associated symptoms. The precise mechanism responsible for its muscle-relaxing effects has not been fully established.
For additional patient-oriented information, see MedlinePlus: Carisoprodol.
Carisoprodol acts on the brain and nervous system to promote muscle relaxation. Its precise mechanism for relieving discomfort associated with acute musculoskeletal conditions is not completely understood.
Because it can cause central nervous system depression, patients may experience drowsiness or dizziness while taking the medication.
The FDA-approved labeling states that the recommended adult dosage of Soma is 250mg to 350mg three times daily and at bedtime. Treatment should generally be limited to two or three weeks, because adequate evidence for longer-term effectiveness has not been established.
Patients should take Soma exactly as prescribed and should not increase the dose or frequency without medical guidance.
Possible side effects of carisoprodol include:
Drowsiness
Dizziness
Headache
Reduced alertness
Impaired coordination
Drowsiness, dizziness, and headache are among the most commonly reported adverse reactions.
If severe, unusual, or persistent symptoms occur, contact a healthcare professional.
Soma can impair alertness and motor coordination. Patients should avoid driving, operating machinery, or performing hazardous activities until they know how the medication affects them.
Alcohol and other sedating medicines require particular caution. Combining carisoprodol with alcohol, opioids, benzodiazepines, or other central nervous system depressants can increase sedation and may increase the risk of serious adverse effects.
Carisoprodol can also be associated with abuse, dependence, and withdrawal, so it should be used only under appropriate medical supervision.
Soma is contraindicated in people with:
A history of acute intermittent porphyria
A hypersensitivity reaction to carisoprodol or a related carbamate such as meprobamate
Patients should tell their healthcare provider about their complete medical history and all prescription, nonprescription, and herbal products they use.
Store Soma according to the product labeling, generally at controlled room temperature. Keep prescription medication in a secure location and out of reach of children and other people who should not take it.
Yes. Soma contains carisoprodol, a skeletal muscle relaxant prescribed for acute, painful musculoskeletal conditions in adults.
Yes. In the United States, Soma (carisoprodol) is classified as a Schedule IV controlled substance.
The FDA-approved labeling recommends limiting treatment to two or three weeks because long-term effectiveness has not been adequately established.
Alcohol can increase the sedative effects of carisoprodol. The prescribing information advises avoiding alcoholic beverages while taking Soma.
Combining carisoprodol with opioids can increase central nervous system depression and sedation. Such combinations should only be used when specifically directed and monitored by a healthcare professional.
Enter your details to launch our secure web Audio call room instantly!
I have been a loyal customer of this auto parts company for years and I cannot.